Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CCR5”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01240811
What this trial is testing

Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception

Who this might be right for
Genital Tract Mucosal ImmunityGenital Tract Microflora
Sharon Achilles 42
Not applicableStudy completedNCT03969550
What this trial is testing

Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

Who this might be right for
AIDSProgressive Multifocal Leucoencephalopathy (PML)
Fondation Ophtalmologique Adolphe de Rothschild 34
Testing effectiveness (Phase 2)WithdrawnNCT05730673
What this trial is testing

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Who this might be right for
CCR5Microsatellite StableMetastatic+1 more
CytoDyn, Inc.
Testing effectiveness (Phase 2)Study completedNCT00764465
What this trial is testing

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

Who this might be right for
Healthy
Garden State Infectious Disease Associates, PA 45
Post-approval studies (Phase 4)Study completedNCT01378910
What this trial is testing

Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia

Who this might be right for
HIV
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 74
Post-approval studies (Phase 4)Study completedNCT00925756
What this trial is testing

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

Who this might be right for
HIV Infections
University of California, San Diego 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT06699836
What this trial is testing

CLOVER - CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
CytoDyn, Inc. 66
Not applicableNot Yet RecruitingNCT06582797
What this trial is testing

Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor

Who this might be right for
HIV-1-infection
University of Kansas Medical Center 10
Not applicableStudy completedNCT01736813
What this trial is testing

CCR5-blockade in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm MetastasisLiver Metastases
National Center for Tumor Diseases, Heidelberg 12
Early research (Phase 1)Study completedNCT01300988
What this trial is testing

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

Who this might be right for
HIV Infection
University of Pennsylvania 18
Testing effectiveness (Phase 2)Study completedNCT03631407
What this trial is testing

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 41
Testing effectiveness (Phase 2)Study completedNCT00393120
What this trial is testing

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

Who this might be right for
HIV Infections
Incyte Corporation 45
Testing effectiveness (Phase 2)Study completedNCT01092104
What this trial is testing

A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00795444
What this trial is testing

Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1

Who this might be right for
HIV-1
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Post-approval studies (Phase 4)Study completedNCT01866267
What this trial is testing

Switching Undetectables to Selzentry

Who this might be right for
Human Immunodeficiency VirusAIDS
St. Hope Foundation 31
Testing effectiveness (Phase 2)Study completedNCT02330549
What this trial is testing

ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD

Who this might be right for
Prediabetic StateNon-alcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
Tobira Therapeutics, Inc. 45
Large-scale testing (Phase 3)Ended earlyNCT01345630
What this trial is testing

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Who this might be right for
HIV-1
ViiV Healthcare 813
Not applicableNo Longer AvailableNCT04313075
What this trial is testing

A Compassionate Use Study of Leronlimab in Breast Cancer

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
CytoDyn, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00197145
What this trial is testing

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 24
Testing effectiveness (Phase 2)Looking for participantsNCT07080567
What this trial is testing

Manipulating the Peri-Infarct Area Using Maraviroc to Enhance Motor Skills After Stroke

Who this might be right for
Ischemic StrokeStrokeStroke Acute
Emmanuel Carrera 80
Next Page